TLR3 deficiency in herpes simplex encephalitis: High allelic heterogeneity and recurrence risk

Neurology

Volumn 83, Issue 21, 2014, Pages 1888-1897

  Lim, Hye Kyung ^a,b,c   Seppänen, Mikko ^d   Hautala, Timo ^f   Ciancanelli, Michael J ^a   Itan, Yuval ^a   Lafaille, Fabien G ^a   Dell, William ^a   Lorenzo, Lazaro ^b   Byun, Minji ^a   Pauwels, Elodie ^a   Rönnelid, Ylva ^a   Cai, Xin ^b,c   Boucherit, Soraya ^b,c   Jouanguy, Emmanuelle ^a,b,c   Paetau, Anders ^g   Lebon, Pierre ^h   Rozenberg, Flore ^h   Tardieu, Marc ⁱ   Abel, Laurent ^a,b,c   Yildiran, Alisan ^j   Vergison, Anne ^k   Roivainen, Reina ^e,g   Etzioni, Amos ^l   Tienari, Pentti J ^e,g   Casanova, Jean Laurent ^a,b,c,m,n   Zhang, Shen Ying ^a,b,c   more..

^a ROCKEFELLER UNIVERSITY   (United States)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Division of Infectious Diseases   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

^h université Paris Cité   (France)

ⁱ BICÊTRE HOSPITAL   (France)

^j ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^k FREE UNIVERSITY OF BRUSSELS   (Belgium)

^l MEYER CHILDREN S HOSPITAL   (Israel)

^m HÔPITAL NECKER ENFANTS MALADES   (France)

ⁿ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TLR3 PROTEIN, HUMAN;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FIBROBLAST; GENE FREQUENCY; GENE SEQUENCE; HAPLOINSUFFICIENCY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HETEROZYGOTE; HUMAN; INFECTION SENSITIVITY; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; CELL CULTURE; DEFICIENCY; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; GENETICS; INFANT; MALE; MUTATION; PEDIGREE; PRESCHOOL CHILD; RECURRENT DISEASE; RISK FACTOR;

ADOLESCENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; GENE FREQUENCY; HUMANS; INFANT; MALE; MUTATION; PEDIGREE; RECURRENCE; RISK FACTORS; TOLL-LIKE RECEPTOR 3;

EID: 84961291816     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000999     Document Type: Article

References (34)

1. Barreiro LB, Ben-Ali M, Quach H, et al. Evolutionary dynamics of human toll-like receptors and their different contributions to host defense. PLoS Genet 2009;5: e1000562.
2. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996;219: 339-349.
3. Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16:17-23.
4. Abel L, Plancoulaine S, Jouanguy E, et al. Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J Pediatr 2010;157:623-629.
5. De Tiege X, Rozenberg F, Heron B. The spectrum of herpes simplex encephalitis in children. Eur J Paediatr Neurol 2008;12:72-81.
6. Zhang SY, Herman M, Ciancanelli MJ, et al. TLR3 immunity to infection in mice and humans. Curr Opin Immunol 2013;25:19-33.
7. Lafaille FG, Pessach IM, Zhang SY, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012;491:769-773.
8. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522-1527.
9. Guo Y, Audry M, Ciancanelli M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 2011;208:2083-2098.
10. Sun Y, Leaman DW. Ectopic expression of toll-like recep-tor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J Interferon Cyto-kine Res 2004;24:350-361.
11. Desai P, Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J Virol 1998;72:7563-7568.
12. Cann HM, de Toma C, Cazes L, et al. A human genome diversity cell line panel. Science 2002;296:261-262.
13. Adzhubei I, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249.
14. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-1081.
15. Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309:581-585.
16. Bell JK, Botos I, Hall PR, et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A 2005;102:10976-10980.
17. Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci U S A 2006;103:8792-8797.
18. de Bouteiller O, Merck E, Hasan UA, et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 2005;280:38133-38145.
19. Ranjith-Kumar CT, Miller W, Xiong J, et al. Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J Biol Chem 2007;282:7668-7678.
20. Takada E, Okahira S, Sasai M, Funami K, Seya T, Matsumoto M. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Mol Immunol 2007;44:3633-3640.
21. Liu L, Botos I, Wang Y, et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008;320:379-381.
22. Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure 2011;19:447-459.
23. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003;4:161-167.
24. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003;301:640-643.
25. Toscano F, Estornes Y, Virard F, et al. Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol 2013;190:764-773.
26. Garcia-Cattaneo A, Gobert FX, Muller M, et al. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A 2012;109:9053-9058.
27. Stojdl DF, Lichty BD, tenOever BR, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003; 4:263-275.
28. Chapgier A, Wynn RF, Jouanguy E, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006;176:5078-5083.
29. Chapgier A, Kong XF, Boisson-Dupuis S, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest 2009;119:1502-1514.
30. Spiegel R, Miron D, Yodko H, Lumelsky D, Habib A, Horovitz Y. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinico-pathological report and review. J Child Neurol 2008;23: 344-348.
31. Valencia I, Miles DK, Melvin J, et al. Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature. Neuropediatrics 2004;35: 371-376.
32. Asenbauer B, McEntagart M, King MD, Gallagher P, Burke M, Farrell MA. Chronic active destructive herpes simplex encephalitis with recovery of viral DNA 12 years after disease onset. Neuropediatrics 1998;29:120-123.
33. Nicoll JA, Love S, Kinrade E. Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis. Neurosci Lett 1993;157:215-218.
34. Lellouch-Tubiana A, Fohlen M, Robain O, Rozenberg F. Immunocytochemical characterization of long-term persistent immune activation in human brain after herpes simplex encephalitis. Neuropathol Appl Neurobiol 2000;26: 285-294.